Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Assets (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Return on Assets for 14 consecutive years, with 2.87% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 103.0% to 2.87% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.87% through Dec 2025, down 103.0% year-over-year, with the annual reading at 2.37% for FY2025, 78.0% down from the prior year.
  • Return on Assets hit 2.87% in Q4 2025 for Guided Therapeutics, down from 2.86% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.99% in Q2 2021 to a low of 2.87% in Q4 2025.
  • Historically, Return on Assets has averaged 1.56% across 5 years, with a median of 1.78% in 2024.
  • Biggest YoY gain for Return on Assets was 568bps in 2021; the steepest drop was -322bps in 2021.
  • Year by year, Return on Assets stood at 1.02% in 2021, then fell by -18bps to 1.2% in 2022, then crashed by -64bps to 1.97% in 2023, then rose by 6bps to 1.84% in 2024, then tumbled by -56bps to 2.87% in 2025.
  • Business Quant data shows Return on Assets for GTHP at 2.87% in Q4 2025, 2.86% in Q3 2025, and 2.67% in Q2 2025.